oxymatrine has been researched along with s20098 in 1 studies
| Studies (oxymatrine) | Trials (oxymatrine) | Recent Studies (post-2010) (oxymatrine) | Studies (s20098) | Trials (s20098) | Recent Studies (post-2010) (s20098) |
|---|---|---|---|---|---|
| 412 | 16 | 270 | 624 | 87 | 422 |
| Protein | Taxonomy | oxymatrine (IC50) | s20098 (IC50) |
|---|---|---|---|
| Melatonin receptor type 1A | Homo sapiens (human) | 0.0001 | |
| Melatonin receptor type 1B | Homo sapiens (human) | 0.0001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, L; Han, F; Jia, Y; Jiang, N; Long, S; Lu, Y; Shan, Z; Yu, J | 1 |
1 other study(ies) available for oxymatrine and s20098
| Article | Year |
|---|---|
Oxymatrine ameliorates agomelatine-induced hepatocyte injury through promoting proteasome-mediated CHOP degradation.
Topics: Acetamides; Alkaloids; Apoptosis; Cell Line; Hepatocytes; Humans; Proteasome Endopeptidase Complex; Protective Agents; Quinolizines; Signal Transduction; Transcription Factor CHOP | 2019 |